Grey Wolf Animal Health Corp. (TSXV: WOLF)

Market Cap	39.32M
Revenue (ttm)	26.30M
Net Income (ttm)	921.89K
Shares Out	34.19M
EPS (ttm)	0.03
PE Ratio	38.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,299
Open	1.060
Previous Close	1.140
Day's Range	1.060 - 1.120
52-Week Range	0.600 - 1.180
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 11, 2025

About Grey Wolf Animal Health

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. It operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. The company engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics. It provides pharmaceuticals, which includes sedaject, ataject, and thyro-tabs canine drugs; and wound care products, including medical tubes, viscose net dressings, elastic bandages, and silicone perforated tapes, as w...

• Industry: Personal Services
• Sector: Consumer Discretionary
• CEO: Angela Cechetto
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: WOLF

Financial Performance

In 2023, Grey Wolf Animal Health's revenue was 25.41 million, an increase of 12.26% compared to the previous year's 22.64 million. Earnings were 609,582, a decrease of -76.03%.